tiprankstipranks
Top Stocks
Top Analyst StocksTop Smart Score StocksTop Insiders Stocks
Popular
Stock ScreenerTop Online Growth StocksTrending StocksPenny Stock Screener
Dividend Investing
Dividend CalculatorDividend Yield CalculatorDividend StocksDividend NewsDividend Calendar
ETFs
ETF CenterSPY ETFQQQ ETF
Stock Comparison
ChatGPT StocksValue StocksAirline StocksAI StocksOil StocksBank StocksFAANG StocksCompare More Stocks…
Calendars
IPO CalendarEarnings Calendar
Popular
Dividend CalendarEconomic Calendar
New
Market HolidaysDaily Analyst RatingsDaily Insider Trading
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Stock Market NewsStock Analysis & Ideas
Popular
ETF NewsGlobal Markets NewsExpert SpotlightTipRanks LabsEarnings Reports InsightsMarket BreakdownsDividend Stock NewsCrypto News
My PortfolioMy PerformanceMy Portfolio AnalysisCrowd InsightsMy Watchlist
About Us
About TipRanksContact Us
Working with TipRanks
Enterprise SolutionsTools for Trading PlatformsData for Hedge FundsBest Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert Center
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Smart Score Stocks
Analysts' Hot Stocks
Insiders' Hot Stocks
Popular
Trending Stocks
Fastest Growing Websites
Hot
Penny Stocks
Market Movers
My Experts
Top Firms
Top Wall Street Analysts
Top Financial Bloggers
Top Corporate Insiders
Popular
Top Hedge Fund Managers
Top Individual Investors
Stock Screener
Stock Comparison
Dividend Calculator
Popular
ETF Center
Dividend Yield Calculator
Daily Stock Ratings
Daily Insider Transactions
Stock ComparisonPOPULAR COMPARISONS
Dividend Stocks
ChatGPT Stocks
Airline Stocks
AI Stocks
My Portfolio
My Performance
My Portfolio Analysis
Crowd Insights
Earnings Calendar
Popular
Dividend Calendar
Economic Calendar
New
IPO Calendar
Stock Market Holidays
Market News
ETF News
Stock Analysis & Ideas
Popular
Global Markets News
Expert Spotlight
Tipranks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
About TipRanks
For Business
Become an Affiliate
Reviews
Contact Us
Plans & Pricing

CLSD Stock Latest News

Clearside Biomedical price target lowered to $4.00 from $5.00 at Needham
The FlyClearside Biomedical price target lowered to $4.00 from $5.00 at Needham
12d ago
CLSD
Clearside Biomedical reports Q4 EPS (16c), consensus (13c)
The FlyClearside Biomedical reports Q4 EPS (16c), consensus (13c)
12d ago
CLSD
Clearside Biomedical Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
Press ReleasesClearside Biomedical Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
12d ago
CLSD
Clearside Biomedical to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update on Thursday, March 9, 2023
Press ReleasesClearside Biomedical to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update on Thursday, March 9, 2023
27d ago
CLSD
Clearside Biomedical announces presentations on CLS-AX OASIS trial
The FlyClearside Biomedical announces presentations on CLS-AX OASIS trial
29d ago
CLSD
Clearside Biomedical Announces Positive Data Presentations on CLS-AX OASIS Clinical Trial and Use of SCS Microinjector® Presented at the Angiogenesis and Macula Society Annual Meetings
Press ReleasesClearside Biomedical Announces Positive Data Presentations on CLS-AX OASIS Clinical Trial and Use of SCS Microinjector® Presented at the Angiogenesis and Macula Society Annual Meetings
29d ago
CLSD
Clearside Biomedical OASIS Data to be Presented at Multiple Upcoming Medical Meetings in February 2023
Press ReleasesClearside Biomedical OASIS Data to be Presented at Multiple Upcoming Medical Meetings in February 2023
1M ago
CLSD
Clearside Biomedical announces leadership update
The FlyClearside Biomedical announces leadership update
1M ago
CLSD
Clearside Biomedical Announces Leadership Team Update
Press ReleasesClearside Biomedical Announces Leadership Team Update
1M ago
CLSD
3 Stocks to Buy Today, 2/3/2023, According to Top Analysts
Market News3 Stocks to Buy Today, 2/3/2023, According to Top Analysts
2M ago
LAC
CLSD
Clearside Biomedical Announces Positive 6-Month Results from OASIS Extension Study with Suprachoroidal CLS-AX (axitinib injectable suspension) in Wet AMD
Press ReleasesClearside Biomedical Announces Positive 6-Month Results from OASIS Extension Study with Suprachoroidal CLS-AX (axitinib injectable suspension) in Wet AMD
2M ago
CLSD
Clearside Biomedical announces 6-month results from OASIS extension study
The FlyClearside Biomedical announces 6-month results from OASIS extension study
2M ago
CLSD
2 “Strong Buy” Penny Stocks That Could Go Boom
Stock Analysis & Ideas2 “Strong Buy” Penny Stocks That Could Go Boom
3M ago
CLSD
FUSN
Cantor Fitzgerald pharma/biotech analysts hold a dinner
The FlyCantor Fitzgerald pharma/biotech analysts hold a dinner
3M ago
JNJ
NVS
Cantor Fitzgerald pharma/biotech analyst hold a luncheon
The FlyCantor Fitzgerald pharma/biotech analyst hold a luncheon
3M ago
JNJ
NVS
Cantor Fitzgerald pharma/biotech analyst hold a luncheon
The FlyCantor Fitzgerald pharma/biotech analyst hold a luncheon
3M ago
JNJ
NVS
Cantor Fitzgerald pharma/biotech analysts hold a dinner
The FlyCantor Fitzgerald pharma/biotech analysts hold a dinner
3M ago
JNJ
NVS
Cantor Fitzgerald pharma/biotech analysts hold a dinner
The FlyCantor Fitzgerald pharma/biotech analysts hold a dinner
4M ago
JNJ
NVS
Cantor Fitzgerald pharma/biotech analyst hold a luncheon
The FlyCantor Fitzgerald pharma/biotech analyst hold a luncheon
4M ago
JNJ
NVS
Clearside Biomedical to Participate in Multiple Upcoming Investor and Ophthalmology Conferences in November and December 2022
Press ReleasesClearside Biomedical to Participate in Multiple Upcoming Investor and Ophthalmology Conferences in November and December 2022
4M ago
CLSD
Clearside Biomedical to Participate in a Fireside Chat at the Stifel 2022 Healthcare Conference
Press ReleasesClearside Biomedical to Participate in a Fireside Chat at the Stifel 2022 Healthcare Conference
4M ago
CLSD
Clearside Biomedical price target raised to $6 from $5 at H.C. Wainwright
The FlyClearside Biomedical price target raised to $6 from $5 at H.C. Wainwright
4M ago
CLSD
Clearside Biomedical expects cash to provide financial runway into 2024
The FlyClearside Biomedical expects cash to provide financial runway into 2024
4M ago
CLSD
Clearside Biomedical reports Q3 EPS (13c), consensus (3c)
The FlyClearside Biomedical reports Q3 EPS (13c), consensus (3c)
4M ago
CLSD
Clearside Biomedical Announces Third Quarter 2022 Financial Results and Provides Corporate Update
Press ReleasesClearside Biomedical Announces Third Quarter 2022 Financial Results and Provides Corporate Update
4M ago
CLSD
Clearside Biomedical Announces Positive Results in Safety, Durability and Biologic Effect in OASIS Phase 1/2a Clinical Trial of Suprachoroidal CLS-AX (axitinib injectable suspension) in Wet AMD Patients
Press ReleasesClearside Biomedical Announces Positive Results in Safety, Durability and Biologic Effect in OASIS Phase 1/2a Clinical Trial of Suprachoroidal CLS-AX (axitinib injectable suspension) in Wet AMD Patients
4M ago
CLSD
Clearside Biomedical to Report OASIS Phase 1/2a Clinical Trial Results and Host Conference Call on Wednesday, November 9, 2022 in Conjunction with Third Quarter 2022 Financial Results
Press ReleasesClearside Biomedical to Report OASIS Phase 1/2a Clinical Trial Results and Host Conference Call on Wednesday, November 9, 2022 in Conjunction with Third Quarter 2022 Financial Results
4M ago
CLSD
Clearside Biomedical to Report Third Quarter 2022 Financial Results and Provide Corporate Update on Wednesday, November 9, 2022
Press ReleasesClearside Biomedical to Report Third Quarter 2022 Financial Results and Provide Corporate Update on Wednesday, November 9, 2022
5M ago
CLSD
Positive Data Presentations at AAO Annual Meeting Demonstrate Utility and Versatility of Clearside Biomedical’s Proprietary Suprachoroidal Space Platform
Press ReleasesPositive Data Presentations at AAO Annual Meeting Demonstrate Utility and Versatility of Clearside Biomedical’s Proprietary Suprachoroidal Space Platform
6M ago
CLSD
tipranks
TipRanks is a comprehensive research tool that helps investors make better, data-driven investment decisions.
Find Us on
twitterstocktwitsfacebooklinkedininstagram
Newsletter SubscriptionEnter your email to receive our newsletter
iosandroid
SitemapTerms of UsePrivacy PolicyFAQ
Research ToolsTop Smart Score StocksTrending StocksDaily Stock RatingsStock ScreenerStock ComparisonAnalysts' Top StocksDaily Insider TransactionsInsiders' Hot StocksExpert Center
CalendarsEarnings CalendarDividend CalendarIPO CalendarStock Market Holidays
EducationGlossaryTipRanks Labs
PlansPlans & PricingAPI for Institutions
CompanyAbout TipRanksContact UsReviews
Disclaimer: The TipRanks Smart Score performance is based on backtested results. Backtested performance is not an indicator of future actual results. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. Backtested results are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. General assumptions include: XYZ firm would have been able to purchase the securities recommended by the model and the markets were sufficiently liquid to permit all trading. Changes in these assumptions may have a material impact on the backtested returns presented. Certain assumptions have been made for modeling purposes and are unlikely to be realized. No representations and warranties are made as to the reasonableness of the assumptions. This information is provided for illustrative purposes only. Backtested performance is developed with the benefit of hindsight and has inherent limitations. Specifically, backtested results do not reflect actual trading or the effect of material economic and market factors on the decision-making process. Since trades have not actually been executed, results may have under- or over-compensated for the impact, if any, of certain market factors, such as lack of liquidity, and may not reflect the impact that certain economic or market factors may have had on the decision-making process. Further, backtesting allows the security selection methodology to be adjusted until past returns are maximized. Actual performance may differ significantly from backtested performance. Backtested results are adjusted to reflect the reinvestment of dividends and other income and, except where otherwise indicated, are presented gross-of fees and do not include the effect of backtested transaction costs, management fees, performance fees or expenses, if applicable. Please note all regulatory considerations regarding the presentation of fees must be taken into account. No cash balance or cash flow is included in the calculation.